ES8600940A1 - Procedimiento de obtencion de composiciones de eicosanoides para profilaxis de estados concerigenos. - Google Patents

Procedimiento de obtencion de composiciones de eicosanoides para profilaxis de estados concerigenos.

Info

Publication number
ES8600940A1
ES8600940A1 ES525841A ES525841A ES8600940A1 ES 8600940 A1 ES8600940 A1 ES 8600940A1 ES 525841 A ES525841 A ES 525841A ES 525841 A ES525841 A ES 525841A ES 8600940 A1 ES8600940 A1 ES 8600940A1
Authority
ES
Spain
Prior art keywords
composition
prophylactic substance
prophylactic
substance
eicosanoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES525841A
Other languages
English (en)
Other versions
ES525841A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sentrachem Ltd
Original Assignee
Sentrachem Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sentrachem Ltd filed Critical Sentrachem Ltd
Publication of ES8600940A1 publication Critical patent/ES8600940A1/es
Publication of ES525841A0 publication Critical patent/ES525841A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE COMPOSICIONES DE EICOSANOIDES PARA LA PROFILAXIS DE ESTADOS CANCERIGENOS. COMPRENDE: PONER EN CONTACTO UN C18:3V6 QUE ES UN G-LINOLENICO CON UN ELONGASA EN PRESENCIA DE UN EXCIPIENTE FARMACEUTICAMENTE ACEPTABLE PARA OBTENER UN C20:3V6 QUE ES UN DIHOMO-GLINOLENICO FORMADO POR PGE1 PGF1 Y TXA1; Y HACER REACCIONAR EL DIHOMO-G-LINOLENICO CON UN D5 DESATURASA PARA OBTENER C20:4V6 QUE ES UN ARAQUIELONICO FORMADO POR UNA MEZCLA DE PGE2 PGE3 PGF2 PGF3 Y OTRAS MEZCLAS DE EICOSANOIDES. SE UTILIZAN PARA PREVER EL CANCER.
ES525841A 1982-09-22 1983-09-22 Procedimiento de obtencion de composiciones de eicosanoides para profilaxis de estados concerigenos. Granted ES525841A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA826965 1982-09-22

Publications (2)

Publication Number Publication Date
ES8600940A1 true ES8600940A1 (es) 1985-11-01
ES525841A0 ES525841A0 (es) 1985-11-01

Family

ID=25576281

Family Applications (1)

Application Number Title Priority Date Filing Date
ES525841A Granted ES525841A0 (es) 1982-09-22 1983-09-22 Procedimiento de obtencion de composiciones de eicosanoides para profilaxis de estados concerigenos.

Country Status (13)

Country Link
EP (1) EP0106571A3 (es)
JP (1) JPS59134721A (es)
AU (1) AU1933383A (es)
BE (1) BE897806A (es)
CA (1) CA1225597A (es)
DE (1) DE3334323A1 (es)
ES (1) ES525841A0 (es)
FR (1) FR2538249B1 (es)
GB (1) GB2134782B (es)
IL (1) IL69782A (es)
IT (1) IT1205345B (es)
NL (1) NL8303264A (es)
NZ (1) NZ205689A (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US4752618A (en) * 1984-07-12 1988-06-21 New England Deaconess Hospital Method of minimizing efects of infection through diet
AU4595985A (en) * 1984-08-10 1986-02-13 Sentrachem Limited Cancer treatment
GB8425006D0 (en) * 1984-10-03 1984-11-07 Efamol Ltd Composition of copper/fatty acids
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
GB8603621D0 (en) * 1986-02-14 1986-03-19 Habib N Modifying lipid structure of cell membranes
AU601238B2 (en) * 1986-11-13 1990-09-06 Efamol Holdings Plc A method of treatment of pregnancy induced hypertension
US5599840A (en) * 1986-11-26 1997-02-04 Bar Ilan University Physiologically active and nutritional composition
US4851431A (en) * 1986-11-26 1989-07-25 Bar Ilan University Physiologically active and nutritional composition
GB8729751D0 (en) * 1987-12-21 1988-02-03 Norsk Hydro As Feed additive & feed containing such additive
IL91802A (en) * 1988-10-27 1994-05-30 Univ Bar Ilan Preparations containing linoleic acid history for the treatment of Alzheimer's, similar brain diseases, and epilepsy
DE3901048A1 (de) * 1989-01-14 1990-07-19 Chimicasa Gmbh Antikachectikum
GB8906369D0 (en) * 1989-03-20 1989-05-04 Tisdale Michael J Eicosapentaenoic acid
US5457130A (en) * 1989-03-20 1995-10-10 Cancer Research Campaign Technology Limited Eicosapentaenoic acid used to treat cachexia
EP0391218B1 (en) * 1989-04-04 1996-03-13 Beiersdorf Aktiengesellschaft Agent for the atopy prophylaxis
GB8918294D0 (en) * 1989-08-10 1989-09-20 Efamol Holdings Pharmaceutical compositions
GB2254556B (en) * 1991-04-11 1995-04-12 Fisons Plc Formulations containing linolenic acid
JPH06511479A (ja) * 1991-06-24 1994-12-22 ウィメンズ　アンド　チルドレンズ　ホスピタル マラリアおよびその他の疾患を治療するための方法および組成物
GB9301446D0 (en) * 1993-01-26 1993-03-17 Scotia Holdings Plc Internal radiation damage
GB9403855D0 (en) 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
CA2436650A1 (en) 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
GB1506563A (en) * 1974-04-25 1978-04-05 Williams J Immunosuppressive agents
DE2967049D1 (en) * 1978-04-11 1984-07-19 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
IE51145B1 (en) * 1980-03-07 1986-10-15 Efamol Ltd Pharmaceutical and dietary compositions
IE53332B1 (en) * 1980-03-14 1988-10-26 Efamol Ltd Pharmaceutical compositions
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
EP0071357B1 (en) * 1981-07-14 1985-01-02 Efamol Limited Pharmaceutical and dietary composition when used for enhancement of 1-series pg production
EP0087865B1 (en) * 1982-03-01 1986-10-01 Efamol Limited Pharmaceutical composition

Also Published As

Publication number Publication date
IT1205345B (it) 1989-03-15
IL69782A (en) 1987-12-20
GB2134782B (en) 1987-03-04
FR2538249B1 (fr) 1986-01-31
FR2538249A1 (fr) 1984-06-29
AU1933383A (en) 1984-03-29
CA1225597A (en) 1987-08-18
EP0106571A3 (en) 1984-07-25
NL8303264A (nl) 1984-04-16
IT8349009A0 (it) 1983-09-22
EP0106571A2 (en) 1984-04-25
NZ205689A (en) 1986-06-11
DE3334323A1 (de) 1984-03-29
GB8325337D0 (en) 1983-10-26
BE897806A (fr) 1984-01-16
GB2134782A (en) 1984-08-22
JPS59134721A (ja) 1984-08-02
ES525841A0 (es) 1985-11-01

Similar Documents

Publication Publication Date Title
ES8600940A1 (es) Procedimiento de obtencion de composiciones de eicosanoides para profilaxis de estados concerigenos.
DE3166441D1 (en) Novel antihistamines, process for their preparation and pharmaceutical compositions containing them
DE3368303D1 (en) Cellulosic materials made transparent and their application, process for their manufacture and the treating compositions
PH15145A (en) Antihypercholesteraemic agent,monacolin k.process for the production and compositions containing same
IE830227L (en) Pyrazolooxazines
IL67697A (en) 6-substituted-s-triazolo(3,4-a)phthalazine derivatives,their preparation and pharmaceutical compositions containing them
ES8605956A1 (es) Procedimiento para preparar una composicion antiacido
ZA831152B (en) Process for producing tert.butyl alkyl ethers in the presence of butadiene
JPS5711949A (en) Arylethanolamine derivatives,manufacture and medicinal composition containing them
AU7592387A (en) Process for the production of mixed alcohols
JO1406B1 (en) Chemical compounds
DE3375491D1 (en) New fibrinolytic enzymes, methods for their production and pharmaceutical compositions containing them
EP0096890A3 (en) Oxazoleacetic acid derivatives, process for their production and compositions containing said derivatives
ES8700652A1 (es) Un metodo de preparar n-4-(3-aminopropil)-aminobutil-2,2-di-hidroxietanoamida
IL70324A0 (en) Ethers,their production and pharmaceutical compositions containing them
JPS5246088A (en) Preparation of novel addition products
ES486851A1 (es) Un procedimiento de preparacion de acido 3a,7b-dihidroxico- lanico
DE3360015D1 (en) 2-methoxyethyl-cyclododecenyl ether, process for its production and its use in the production of 2-methoxyethyl-cyclododecyl ether
JPS521096A (en) Process of manufacturing vinegar
AU578125B2 (en) Pyrazine diazohydroxide compounds
JPS5247484A (en) Method for producing zeolite-adsorbed active feed containing various d igestive enzymes and their producing bacteria
PT73242B (en) Process for the preparation of wine stabilizing compositions
JO975B1 (en) Imidisole, the method of its preparation and the active medicinal ingredients contained in it.
JPS527483A (en) Prparation of cholesterol esterase
GEP19940126B (en) Glass for Glassfibre

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000201